...
首页> 外文期刊>Journal of pharmacy practice >Pharmacist-Managed Antimicrobial Stewardship Program for Patients Discharged From the Emergency Department
【24h】

Pharmacist-Managed Antimicrobial Stewardship Program for Patients Discharged From the Emergency Department

机译:由急诊科出院的药剂师管理的抗菌药物管理计划

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Positive outcomes of antimicrobial stewardship programs in the inpatient setting are well documented, but the benefits for patients not admitted to the hospital remain less clear. This report describes a retrospective case-control study of patients discharged from the emergency department (ED) with subsequent positive cultures conducted to determine whether integrating antimicrobial stewardship responsibilities into practice of the emergency medicine clinical pharmacist (EPh) decreased times to positive culture follow-up, patient or primary care provider (PCP) notification, and appropriateness of antimicrobial therapy. Pre- and post-implementation groups of an EPh-managed antimicrobial stewardship program were compared. Positive cultures were identified in 177 patients, 104 and 73 in pre- and post-impiementation groups, respectively. Median time to culture review in the pre-implementation group was 3 days (range 1-15) and 2 days (range 0-4) in the post-implementation group (P = .0001). There were 74 (71.2%) and 36 (49.3%) positive cultures that required notification in the pre- and post-implementation groups, respectively, and the median time to patient or PCP notification was 3 days (range 1-9) and 2 days (range 0-4) in the 2 groups (P = .01). No difference was seen in the appropriateness of therapy. In conclusion, EPh involvement reduced time to positive culture review and time to patient or PCP notification when indicated.
机译:住院治疗中抗菌药物管理计划的积极成果已有很好的文件记载,但是对于未入院的患者的收益尚不清楚。本报告描述了对急诊科(ED)出院的患者进行回顾性病例对照研究,并进行了随后的阳性培养,以确定是否将抗菌素管理职责纳入急诊医学临床药剂师(EPh)的实践中,以减少对阳性培养进行随访的时间,患者或初级保健提供者(PCP)通知以及抗微生物治疗的适用性。比较了EPh管理的抗菌药物管理计划的实施前和实施后组。分别在177例患者中发现了阳性培养物,在浸入前和浸入后组中分别检测了104和73例。在实施前组中,进行文化评估的中位时间为3天(范围1-15)和实施后组中的2天(范围0-4)(P = .0001)。实施前和实施后分别有74(71.2%)和36(49.3%)个阳性培养需要通报,并且患者或PCP通报的中位时间为3天(范围1-9)和2 2组中的天数(0-4)(P = 0.01)。治疗的适当性未见差异。总而言之,EPh的介入减少了进行阳性培养物审查的时间,并减少了患者或PCP通知的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号